| Literature DB >> 31796815 |
Dai Miyazaki1, Kazumi Fukagawa2, Atsuki Fukushima3, Hiroshi Fujishima4, Eiichi Uchio5, Nobuyuki Ebihara6, Jun Shoji7, Etsuko Takamura8, Kenichi Namba9, Yuichi Ohashi10, Shigeki Okamoto11, Yoshiyuki Satake12, Hiroshi Ohtsu13, Yumiko Shimizu14, Yoshitsugu Inoue14.
Abstract
Ambient air pollution is a well-recognized risk for various diseases including asthma and heart diseases. However, it remains unclear whether air pollution may also be a risk of ocular allergic diseases. Using a web-based, nation-wide, cross-sectional study design, we examined whether the level of ambient air pollution is significantly associated with the prevalence of ocular allergic diseases. A web-based questionnaire was posted to invite the participants who are members of the Japan Ophthalmologist Association and their family members. The answers from 3004 respondents were used to determine whether there were significant associations between the level of the pollutants and the prevalence of ocular allergic diseases. The study period was between March to May 2017. The data of the air pollutants during 2012 to 2016 were obtained from the National Institute for Environmental Studies. The prevalence of allergic diseases was calculated by post stratification and examined for significant associations with the level of pollutants using multiple logistic regression analyses. The prevalence of seasonal allergic conjunctivitis, perennial allergic conjunctivitis, atopic keratoconjunctivitis (AKC), and vernal keratoconjunctivitis (VKC) in Japan was 45.4%, 14.0%, 5.3%, and 1.2%, respectively. The high prevalence of the severe forms of allergic conjunctivitis, including AKC and VKC, were significantly associated with the levels of the air pollutants. The prevalence of AKC was significantly associated with the levels of NO2 with an odds ratio (OR) of 1.23 (per quintile). The prevalence of VKC was significantly associated with the levels of NOx and PM10 with ORs of 1.72 and 1.54 respectively. The significant associations between the prevalence of AKC and VKC and the levels of air pollutants indicate that clinicians need to be aware that air pollutants may pose serious risks of vision threatening severe ocular allergy.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31796815 PMCID: PMC6890742 DOI: 10.1038/s41598-019-54841-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Levels of ambient air pollutants in 2012 through 2016. The average annual concentration of nitrogen oxides, NO, NO2, and NOx, and oxidant was within 0.1 to 0.2 ppm. Variation trends were almost stationary within recent years. The means of the maximum one-hour concentration of the day were used for PM10, NO, NO2, oxidant, and SO2. The annual 98% values of the day average concentration were used for NOx. The annual mean concentration was available for PM2.5.
Association of ocular allergic diseases with air pollutants in 2016 by multiple logistic regression analysis.
| Vernal keratoconjunctivitis | Atopic keratoconjunctivitis | |||
|---|---|---|---|---|
| Odds ratio | P value | Odds ratio | P value | |
| NO (quintile) | 1.72 | P = 0.002 | 1.21 | P = 0.032 |
| NO2 (quintile) | 1.88 | P = 0.003 | 1.23 | P = 0.028 |
| NOx (quintile) | 1.72 | P = 0.002 | 1.22 | P = 0.029 |
| Oxidant (quintile) | 1.62 | P = 0.017 | 1.13 | P = 0.181 |
| SO2 (quintile) | 1.35 | P = 0.059 | 0.93 | P = 0.387 |
| PM2.5 (quintile) | 1.37 | P = 0.192 | 0.81 | P = 0.013 |
| PM10 (quintile) | 1.54 | P = 0.023 | 1.10 | P = 0.170 |
| NO (quintile) | 1.06 | P = 0.256 | 0.98 | P = 0.717 |
| NO2 (quintile) | 1.05 | P = 0.427 | 1.04 | P = 0.463 |
| NOx (quintile) | 1.07 | P = 0.191 | 0.98 | P = 0.736 |
| Oxidant (quintile) | 1.15 | P = 0.078 | 0.90 | P = 0.064 |
| SO2 (quintile) | 0.88 | P = 0.021 | 1.13 | P = 0.057 |
| PM2.5 (quintile) | 0.92 | P = 0.257 | 0.98 | P = 0.729 |
| PM10 (quintile) | 1.04 | P = 0.378 | 0.97 | P = 0.526 |
Adjusted for age, cedar pollen, allergic rhinitis, and atopic dermatitis.
Figure 2Association of ocular allergic diseases with particle or gaseous pollution by structural equation modeling analysis. The prevalence of ocular and allergic diseases was analyzed for associations with the annual levels of PM10, NO2, NOx, oxidant, and SO2 (per inter-quintile range) in 2016. The means of the maximum one-hour concentration of the day were used for PM10, NO2, oxidant, and SO2. The annual 98% values of the day average concentration were used for NOx. Values of arrows indicate significant co-efficient for disease prevalence expressed as percentage. Vernal keratoconjunctivitis was associated with particle pollutant, PM10 and gaseous NOx. Atopic keratoconjunctivitis was associated with NO2. Seasonal allergic conjunctivitis is positively associated with the levels of oxidant and PM10, but negatively associated with SO2. Allergic rhinitis was significantly associated with the level of NOx. Eczema was positively associated with NO2 but negatively with NOx. Significant covariance of error terms (ε) were observed between ocular and systemic diseases (double-headed arrow). The root mean squared error of approximation (RMSEA): 0.017, Comparative fit index (CFI) = 0.99. *P < 0.05, **P < 0.01, ***P < 0.005, ****P = 0.0000.
Web-based questionnaire.
| A. Primary residence | Selection of 47 prefectures in Japan |
| B. Age | Years |
| C. Sex | Male / Female |
| D. Presence of allergic conjunctivitis | 1. None |
| 2. Seasonal allergic conjunctivitis (Cedar/cypress pollen) | |
| 3. Seasonal allergic conjunctivitis (non- cedar/cypress pollen) | |
| 4. Perennial allergic conjunctivitis | |
| 5. Unknown | |
| E. Presence of severe allergic conjunctivitis | 1. None |
| 2. Atopic keratoconjunctivitis without proliferative lesion | |
| 3. Atopic keratoconjunctivitis with proliferative lesion | |
| 4. Vernal keratoconjunctivitis | |
| 5. Giant papillary conjunctivitis | |
| F. Presence of other allergic diseases | 1. None |
| 2. Allergic rhinitis | |
| 3. Eczema | |
| 4. Asthma | |
| 5. Food allergy | |
| 6. Dry eye | |
| 7. Others | |
| 8. Unknown | |
| G. Daily use of contact lens | 1. None |
| 2. Disposable contact lens | |
| 3. Non disposable soft contact lens | |
| 4. Asthma | |
| 5. Others | |
| 6. Unknown | |
| H. Use of topical medications for allergic conjunctivitis | 1. None |
| 2. Histamine H1 antagonist eye drop | |
| 3. Chemical mediator release inhibitor eye drop | |
| 4. Steroid eye drop | |
| 5. Cyclosporin or tacrolimus eye drop | |
| 6. NSAIDs eye drop | |
| 7. Others | |
| 8. Unknown |